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Background and the purpose of the study: The early stage of diabetes mellitus type 2 is associated with
postprandial hyperglycemia. Hyperglycemia is believed to increase the production of free radicals and reactive
oxygen species, leading to oxidative tissue damage. In an effort of identifying herbal drugs which may become
useful in the prevention or mitigation of diabetes, biochemical activities of Polygonum hyrcanicum and its
constituents were studied.
Methods: Hexane, ethylacetate and methanol extracts of P. hyrcanicum were tested for α-glucosidase inhibitory,
antioxidant and radical scavenging properties. Active constituents were isolated and identified from the methanolic
extract in an activity guided approach.
Results: A methanolic extract from flowering aerial parts of the plant showed notable α-glucosidase inhibitory
activity (IC50 = 15 μg/ml). Thirteen phenolic compounds involving a cinnamoylphenethyl amide, two flavans, and
ten flavonols and flavonol 3-O-glycosides were subsequently isolated from the extract. All constituents showed
inhibitory activities while compounds 3, 8 and 11 (IC50 = 0.3, 1.0, and 0.6 μM, respectively) were the most potent
ones. The methanol extract also showed antioxidant activities in DPPH (IC50 = 76 μg/ml) and FRAP assays
(1.4 mmol ferrous ion equivalent/g extract). A total phenol content of 130 mg/g of the extract was determined
by Folin-Ciocalteu reagent.
Conclusion: This study shows that P. hyrcanicum contains phenolic compounds with in vitro activity that can be
useful in the context of preventing or mitigating cellular damages linked to diabetic conditions.
Keywords: Polygonum hyrcanicum, Polygonaceae, α-Glucosidase, Antioxidant, Cinnamoylphenethyl amide,
FlavonoidIntroduction
The early stage of diabetes mellitus type 2 is associated
with postprandial hyperglycemia due to impaired after-
meal acute insulin secretion. Hyperglycemia is believed
to increase the production of free radicals and reactive
oxygen species, leading to oxidative tissue damage and
diabetic complications such as nephropathy, neuropathy,
retinopathy, and memory impairment [1]. Glucosidases* Correspondence: yasa@sina.tums.ac.ir
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distribution, and reproduction in any mediumare a group of digestive enzymes which break down the
dietary carbohydrates into simple monosaccharides.
Glucosidase inhibitors such as acarbose reduce the rate
of carbohydrate digestion and delay the carbohydrate
absorption from the digestive tract. Therefore, they have
a potential to prevent the development of type 2 diabetes
mellitus by lowering the after-meal glucose levels [2].
Polygonum species are valuable medicinal plants which
possess interesting biological activities such as anti-
inflammation [3], cardiovascular protection [4], neuro-
protection [5], and mitigation of biochemical processes
involved in age-related neurodegenerative disorders such
as Alzheimer’s [6] and Parkinson’s disease [7]. It isCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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due to antioxidant and radical scavenging properties of
the plant. Moreover, some Polygonum species were
reported to possess glucosidase inhibitory properties.
Phenylpropanoid glycosides of P. sachalinense [8] and
tannins of P. cuspidatum [9] were subsequently identi-
fied as active compounds.
Polygonum hyrcanicum is an endemic species that
grows widely in northern areas of Iran [10]. In folk
medicine of the Turkmen Sahra region (southeast of the
Caspian Sea), decoctions made from aerial parts of the
plant are used for the treatment of liver problems,
anemia, hemorrhoids, and kidney stones [11]. To our
knowledge, no biological or phytochemical investigation
has been carried out with this species. To explore the
plant’s properties with respect to potential prevention or
mitigation of cellular damages linked to diabetic condi-
tions, different extracts of P. hyrcanicum were tested for
α-glucosidase inhibitory, antioxidant and radical scaven-
ging properties. Active constituents were isolated and
identified from the methanolic extract.
Material and methods
General
Column chromatography was carried out using silica gel
(230–400 mesh) obtained from Merck (Germany), RP-18
(230–400 mesh) and Sephadex LH-20 procured from
Fluka (Switzerland). Pre-coated silica gel 60 F254 plates and
silica gel 60 RP-18 F254S plates (Merck, Germany) were
used for TLC. Spots were observed under UV at 254 and
366 nm and spraying with anisaldehyde-H2SO4 reagent
(Sigma-Aldrich Chemie, Germany) and heating at 120°C
for 5 min. HPLC separations were performed on a Knauer
Wellchrom system connected to a photodiode array de-
tector (Smart line system, Germany). 1H and 13C NMR
spectra were measured on a Bruker Avance DRX 500
spectrometer operating at 500 MHz for 1H and 125 MHz
for 13C using a 5 mm PABBO probehead. α-glucosidase
(EC 3.2.1.20, from baker’s yeast, 77 U/mg), p-nitrophenyl-
α-d-glucopyranoside, vitamin E 97% and 2, 2-diphenyl-
picrylhydrazyl (DPPH) were obtained from Sigma-Aldrich
Chemie (Germany). Sodium carbonate, FeCl3, sodium
acetate, ferrous sulfate [FeSO4.7H2O], gallic acid, 2, 4,
6-tripyridyl-s-triazine (TPTZ) solution, and Folin-Ciocalteu
reagent were all obtained from Merck (Germany).
Plant materials
Aerial parts of Polygonum hyrcanicum Rech. f. at full
flowering stage were collected in September 2008 near
the village of Veresk (Mazandaran Province) in the north
of Iran. The plant material was identified by the forth
co-author. A voucher specimen (6729-TEH) has been
deposited at the Herbarium of the Faculty of Pharmacy,
Tehran University of Medical Sciences.Extraction and isolation
Shade-dried aerial parts of the plant (1200 g) were cut to
small pieces and macerated with n-hexane, ethyl acetate,
and methanol, successively, at room temperature (3× 48
hours with each solvent). The extracts were concentrated
under reduced pressure, then freeze dried, resulting in
dry extracts of hexane (14 g), ethyl acetate (12 g), and
methanol (150 g).
Methanol extract (150 g) of P. hyrcanicum was sus-
pended in ethyl acetate and divided into an ethyl acet-
ate–soluble portion (ESP, 15 g) and methanol–soluble
portion (MSP, 135 g). The ESP was applied to normal
phase silica gel column chromatography (5 × 45 cm)
and eluted with CHCl3, CHCl3:EtOAc (6:4, 2:8),
EtOAc, and MeOH, successively. Seven fractions (ESP1-7)
were collected. ESP3 (375 mg) and ESP5 (190 mg) were
purified on a Sephadex LH-20 column eluted with MeOH:
EtOAc (2:1), to afford compounds 1 (12 mg) and 2 (4 mg),
respectively. ESP6 (450 mg) was separated on a Sephadex
LH-20 column eluted with MeOH:EtOAc (4:1) to give sub-
fractions ESP6-1–ESP6-6. ESP6-2 (42 mg) was subjected to
RP chromatography on an RP-18 column eluted with a
step gradient of aqueous MeOH (MeOH 40% to 100%).
Compounds 3 (11 mg) and 4 (2 mg) were obtained.
Compounds 5 (3.5 mg) and 6 (5.5 mg) were purified from
ESP6-3 (52 mg) by an RP-18 column eluted with aqueous
MeOH (50% to 100%). ESP6-4 (19 mg) and ESP6-5 (28 mg)
were separately chromatographed on an RP-18 column
eluted with water:MeOH (1:1) to give compounds 7 (5 mg)
and 8 (5 mg), respectively.
A portion of the MSP (20 g) was applied to an RP-18
silica gel column eluted with a step gradient of water:
MeOH (8:2, 7:3, 5:5, 3:7, 0:10), yielding seven sub-
fractions (MSP1–MSP7). Compound 9 (5.6 mg) was
obtained by semi-preparative HPLC of MSP3 (128 mg)
on an RP-18 column (250 × 20 mm, 7 μm). Water (solv-
ent A) and MeOH (solvent B) were used as mobile phase
(0–20 min, 40% B; 20–21 min, 40–50% B; 21-31 min,
50% B; 31–45 min, 50–60% B; 45–46 min, 60–100%
B; 46-51 min, 100% B; flow rate of 4 ml/min). Subfraction
MSP4 (596 mg) was separated on a Sephadex LH-20
column (MeOH) into four fractions (MSP4-1–MSP4-4).
Semi-preparative RP-18 HPLC of MSP4-2 with water
(solvent A) and MeOH (solvent B) as the mobile phase
(0–30 min, isocratic elution with 50% B; 30–35 min,
100% B, lasting for 5 minutes; flow rate: 4 ml/min)
yielded pure 10 (5.4 mg) and 11 (11 mg). MSP4-4 was
separated on a Sephadex LH-20 column (MeOH) to give
compound 12 (7.5 mg). Compound 13 (17 mg) was puri-
fied from MSP5 (1.148 g) by chromatography on a Sepha-
dex LH-20 column eluted with MeOH–water (8:2)
followed by RP-18 chromatography (aqueous MeOH 20–
100%). The purified compounds were identified using
spectroscopic methods (1H and 13C NMR, 2D NMR
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with literature data. The NMR spectra of compound 4
were previously recorded only in acetone-d6 and no 13C-
NMR data have been reported for compound 5 up to
now.
Compound 4: 1 H NMR (DMSO-d6, 500 MHz);
δ= 7.45 (brs, H-2'), 7.43 (d, J= 8.1 Hz, H-6'), 6.92
(d, J= 8.1 Hz, H-5'), 6.45 (brs, H-8), 6.25 (brs, H-6), 5.66
(brs, H-1"), 4.74 (br d, J = 4.1 Hz, H-3"), 4.38 (brs, H-2"),
4.17 (dd, J = 11.7, 3.5 Hz, H-5"), 3.96 (dd, J= 11.7, 6.4 Hz,
H-5"), 3.81 (m, H-4"), 2.13 (s, CH3), 1.98 (s, CH3); 13 C
NMR (DMSO- d6, 125 MHz); δ= 178.0 (C-4), 170.2,
170.5 (COO), 164.5 (C-7), 161.7 (C-5), 157.6 (C-2), 156.7
(C-9), 149.0 (C-4'), 145.5 (C-3'), 133.7 (C-3), 121.5 (C-6'),
121.0 (C-1'), 116.1 (C-2'), 115.6 (C-5'), 108.4 (C-1"), 103.9
(C-10), 99.2 (C-6), 94.0 (C-8), 82.4 (C-4"), 79.4 (C-2"),
79.7 (C-3"), 63.5 (C-5"), 20.7, 20.5 (CH3)
Compound 5: 1 H NMR (MeOD, 500 MHz); δ= 7.47
(brs, H-2'), 7.44 (d, J= 8.2 Hz, H-6'), 6.88 (d, J= 8.2 Hz,
H-5'), 6.37 (brs, H-8), 6.19 (brs, H-6), 5.72 (br s, H-1"),
4.81(d, J= 3.8, H-3"), 4.44 (brs, H-2"), 3.70 (d, J= 3.8,
H-4"), 3.53 (2 H, H-5"), 2.80 (s, CH3); 13 C NMR
(MeOD, 125 MHz); δ= 179.4 (C-4), 172.4 (COO), 166.3
(C-7), 163.1 (C-5), 159.6 (C-2), 158.5 (C-9), 149.6 (C-4'),
146.3 (C-3'), 135.0 (C-3), 123.2 (C-1'), 123.0 (C-6'), 117.3
(C-5'), 116.0 (C-2'), 109.8 (C-1"), 105.7 (C-10), 99.9 (C-6),
94.8 (C-8), 86.8 (C-4"), 81.3 (C-3"), 81.2 (C-2"), 62.5
(C-5"), 20.9 (CH3).
Sugar analysis
Sugar moieties of glycoside structures were detected
by GC-MS analysis after acid hydrolysis and derivati-
zation with L-cysteine methyl ester and silylation
[12].
α-Glucosidase inhibition assay
α-Glucosidase inhibitory activities were evaluated accord-
ing to the chromogenic method described by McCue
et al. (2005), with some modifications [13]. The enzyme
solution contained 20 μl α-glucosidase (0.5 unit/ml) and
120 μl 0.1 M phosphate buffer (pH 6.9). p-Nitrophenyl-
α-D-glucopyranoside (5 mM) in the same buffer (pH
6.9) was used as a substrate solution. Ten microliters of
test samples, dissolved in DMSO at various concentra-
tions, were mixed with enzyme solution in microplate
wells and incubated for 15 min at 37°C. Twenty micro-
liters of substrate solution were added and incubated
for an additional 15 min. The reaction was terminated
by adding 80 μl of 0.2 M sodium carbonate solution.
Absorbance of the wells was measured with a micro-
plate reader at 405 nm, while the reaction system with-
out plant extracts was used as control. The system
without α-glucosidase was used as blank, and acarbose
was used as positive control. Each experiment wasconducted in triplicate. The enzyme inhibitory rates of




The IC50 values of samples were calculated and
reported as the mean ± standard deviation (SD) of three
experiments.
DPPH free radical scavenging activity
The antioxidant activities of the extracts were deter-
mined with the DPPH assay according to an established
protocol [14]. Extract solutions of 500, 250, 100, and 50
μg/ml were prepared in methanol. Each test tube con-
tained 1 ml of the samples and 2 ml freshly prepared
DPPH solution of 40 μg/ml in methanol. Negative con-
trol tubes were the same as the test tubes, except that
they did not include DPPH. Absorbance of the mixtures
were recorded at 517 nm after 30 minutes, against the
blank covets of DPPH solution. Vitamin E was used as a
positive control. All samples were assayed in triplicate
and IC50 values were calculated.
FRAP assay
Antioxidant activities of plant extracts were evaluated by
monitoring their ferric-reducing abilities [15]. Freshly
prepared FRAP reagent contained 5 ml FeCl3 (20 mM)
plus 5 ml of a 10 mM TPTZ solution in 40 mM HCl
and 50 ml of 300 mM acetate buffer (pH=3.6). One
hundred microliters of the samples, dissolved in metha-
nol at various concentrations, were mixed with 3 ml
FRAP reagent and incubated at 37°C for 10 minutes; the
absorptions at 593 nm were recorded. A calibration
curve was generated in the range of 125–750 μM ferrous
sulfate (FeSO4.7H2O). Vitamin E was used as a positive
control and the results were expressed as mmol ferrous
ion equivalent per gram of extracts.
Determination of total phenolic content
Total phenolic contents of extracts were assessed using
Folin-Ciocalteu reagent [16]. The reagent was diluted
10-fold with distilled water. Two hundred microliters of
appropriate dilutions of extracts were added to 1.5 ml
reagent and allowed to stand at room temperature for 5
minutes. Sodium bicarbonate solution (1.5 mL, 60 g/L)
was added to the mixture and stored at room
temperature for an additional 90 minutes; absorptions at
725 nm were recorded. Known concentrations of gallic
acid (0–100 μg/ml in methanol) were applied as stand-
ard samples and a calibration curve was created. Total
phenolic contents were expressed as mg of gallic acid
equivalents (GAE) per gram of dry extracts.





FRAP assay (mmol ferrous ion
equivalent/g)
Total phenol content
(mg gallic acid equivalent/g)
Hexane extract 56.20 ± 1.2 1000< trace trace
EtOAc extract 42.30 ± 0.9 146.6 ± 5.2 0.54 ± 0.21 20.30 ± 2.5
MeOH extract 15.30 ± 0.5 76.00 ± 3.4 1.37 ± 0.42 135.00 ± 4.4
Vitamin E - 14.12 ± 0.9 2.40 ± 0.76 -
Acarbose 8.70 ± 1.1 - - -
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Sequential extraction of the aerial parts of P. hyrcanicum
yielded 1.0% of hexane, 0.8% of ethyl acetate, and 12.5% of
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Figure 1 Structures of the phenolic constituents 1-13 isolated from th
the spectroscopic data with literature [21,26] led to the identificationhyrcanicum showed noticeable α-glucosidase inhibitory ac-
tivity (IC50 = 15.3 μg/ml), whereas the ethyl acetate and
hexane extracts only caused moderate inhibition. Acarbose
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methanol extract resulted in the purification of 13 phen-
olic compounds as the active constituents. Based on NMR
data, the purified compounds were identified as quercetin
(1) [17], myricetin (2) [17], N-trans-caffeoyl-tyramine (3)
[18], quercetin 3-O-α-L-(3",5"-diacetyl-arabinofuranoside)
(4) [19], quercetin 3-O-α-L-(3"-acetyl-arabinofuranoside)
(5) [20], myricetin 3-O-α-L-(3",5"-diacetyl-arabinofurano-
side) (6) [21], (+) catechin (7) [22], (-) gallocatechin (8)
[22], myricetin 3-O-β-D-galactopyranoside (9) [23], myri-
cetin 3-O-α-L-rhamnopyranoside (myricitrin) (10) [23],
quercetin 3-O-β-D-galactopyranoside (11) [24], myricetin
3-O-α-L-arabinofuranoside [21] (12), and quercetin
3-O-α-L-arabinofuranoside (avicularin) (13) [25] (Figure 1).
GC analysis of sugars obtained from hydrolysis of com-
pounds 4, 5, 6, 12, and 13 and comparison with the au-
thentic sample resulted in the detection of L-arabinose
(RT=24.3 min).
The sugar moiety of compounds 9 and 11 were con-
firmed to be D-galactose (RT= 31.1 min) and compound
10 was verified to have an L-rhamnose (RT= 26.7 min).
All the compounds were isolated from P. hyrcanicum for
the first time. Compounds 4, 5, and 6 are rare flavonoids
with mono- or diacetylglycosyl moieties which have not
been detected in the Polygonum genus up to now.
Subsequently, α-glucosidase inhibitory activities of
phenolic compounds 1–13, isolated from the methanolic
extract, were evaluated. The results are reported in
Table 2. All constituents showed interesting inhibitory
activities while compounds 3, 8 and 10 (IC50 = 0.3, 1.0,
and 0.6 μM, respectively) were the most potent ones.
The α-glucosidase inhibitory activities of compounds 4,
5, 6, and 12 have not been reported in the literatureTable 2 α-Glucosidase inhibitory activity (IC50) of
phenolic compounds 1-13
No Compounds IC50 (μM)
1 Quercetin 3.3 ± 2.0
2 Myricetin 1.3 ± 0.6
3 N-trans-Caffeoyl-tyramine 0.3 ± 0.3
4 Quercetin 3-O-α-L-(300,500-diacetyl-arabinofuranoside) 4.9 ± 1.5
5 Quercetin 3-O-α-L-(300-acetylarabinofuranoside) 4.8 ± 1.9
6 Myricetin 3-O-α-L-(300,500-diacetyl-arabinofuranoside) 5.8 ± 2.8
7 (+) Catechin 6.6 ± 3.5
8 (-) Gallocatechin 1.0 ± 0.3
9 Myricetin 3-O-β-D-galactopyranoside 4.8 ± 0.8
10 Myricitrin 0.6 ± 0.2
11 Quercetin 3-O-β-D-galactopyranoside 6.7 ± 3.0
12 Myricetin 3-O-α-L-arabinofuranoside 4.2 ± 2.9
13 Avicularin 7.6 ± 0.9
Acarbose 13.5 ± 1.7previously. Comparing the IC50 values of tested flavo-
noids shows that hydroxyl substitution affects the inhibi-
tory activity so that increasing number of free phenolic
groups results in higher activity.
Since oxidative stress is considered as a key factor in
the pathogenesis of diabetic complications, antioxidant
properties of the extracts were also studied. DPPH rad-
ical scavenging activity and ferric reducing power of
P. hyrcanicum extracts are summarized in Table 1. The
methanolic extract showed noticeable antioxidant activ-
ities in both DPPH (IC50 = 76.0 μg/ml) and FRAP
(1.4 mmol ferrous ion equivalent/g) assays compared to
vitamin E (IC50 = 14.1 μg/ml, FRAP value of 2.4 mmol
ferrous ion equivalent/g) as the positive control. The
ethyl acetate extract was a moderate antioxidant, while
the hexane extract was not active at the concentrations
tested. The antioxidant properties were in accord with
the total phenol content of the extracts (Table 1).
Methanol and ethyl acetate extracts contained 135.0 mg
and 20.3 mg gallic acid equivalent/g, respectively, and
the hexane extract was free of phenolic constituents.
Conclusion
In the perspective of identifying traditional herbal drugs
which might be useful in preventing or mitigating cellu-
lar damages related to diabetes, we carried out the first
study of the Persian edible plant, P. hyrcanicum. The
methanolic extract, in particular, showed promising
α-glucosidase, antioxidant, and radical scavenging activ-
ities and thirteen phenolic compounds were purified in
an activity-guided approach. All the isolated compounds
(IC50 = 0.3–7.6 μM) were more potent than the positive
control acarbose (IC50 = 13.5 μM). This study suggests
that P. hyrcanicum is a promising source of active com-
pounds that can prevent the development of diabetes
mellitus type 2 and its complications. While these
in vitro results are of a preliminary nature, further inves-
tigation of P. hyrcanicum, in particular, in vivo pharma-
cological testing of the methanolic extract is warranted.
These studies will provide a more in depth picture on
the potential of this interesting traditional Persian plant.
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